MedTrace Logo

Interest of Thromboelastography (ROTEM) as a Biomarker of Revascularisation in Stroke

NCT02902393 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 64

Last updated 2016-09-15

No results posted yet for this study

Summary

Revascularisation using recombinant tPA is the reference treatment of stroke. However, the efficacy of fibrinolysis is about 50%. Several factors, including the size of thrombus, have been associated with revascularisation efficacy.

The aim of this prospective study is to evaluate ex vivo the effect of tPA in patients with stroke with thromboelastography and to correlate results with the clinical outcome of patients. Results may predict revascularisation in patients with stroke.

Conditions

Interventions

BIOLOGICAL

Thromboelastography

Sponsors & Collaborators

  • University Hospital, Caen

    lead OTHER

Principal Investigators

  • Richard MACREZ, PhD · University Hospital, Caen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-06-30
Completion
2018-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02902393 on ClinicalTrials.gov